RABEPRAZOLE ALTER 10 mg, gastro-resistant tablet 28 tablets
Active ingredients: RABÉPRAZOLE BASE, Rabeprazole sodium monohydrate
Commercialized according to BDPMDispensing in France: Prescription only
Gastro-resistant tablet28 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- RABEPRAZOLE ALTER 10 mg, comprimé gastro-résistant
- Pharmaceutical form
- comprimé gastro-résistant(e)
- Route of administration
- orale
- Presentation description
- plaquette(s) formée(s) à froid polyamide aluminium PVC de 28 comprimé(s)
- Marketing authorisation holder
- LABORATOIRES ALTER
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 2 Dec 2024
- Prescription and dispensing conditions
- Prescription only
- List II: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
65336041CIP73000292CIP133400930002926Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| RABÉPRAZOLE SODIQUE MONOHYDRATÉcomprimé | 10 mg · un comprimé | SA |
| RABÉPRAZOLE BASEcomprimé | 9,42 mg · un comprimé | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.